Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation.

ABSTRACT:

SUBMITTER: Schonefeldt C 

PROVIDER: S-EPMC3763388 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature